Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease.

about

Pathophysiology and treatment of cardiovascular disease in pediatric chronic kidney disease.

Item

http://www.wikidata.org/entity/Q49908584

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Pathophysiology and treatment ...... iatric chronic kidney disease.

@en

Pathophysiology and treatment ...... iatric chronic kidney disease.

@nl

type

Item

label

Pathophysiology and treatment ...... iatric chronic kidney disease.

@en

Pathophysiology and treatment ...... iatric chronic kidney disease.

@nl

prefLabel

Pathophysiology and treatment ...... iatric chronic kidney disease.

@en

Pathophysiology and treatment ...... iatric chronic kidney disease.

@nl

P1476

Pathophysiology and treatment ...... iatric chronic kidney disease.

@en

P2093

Katherine Wesseling-Perry

http://www.w3.org/2001/XMLSchema#string

Nadine Khouzam

http://www.w3.org/2001/XMLSchema#string

P2860

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Effects of fibrates in kidney disease: a systematic review and meta-analysis

Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension

Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification.

Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease.

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

Heart rate and blood pressure variability in children with chronic kidney disease: a report from the CKiD study

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

P2888

s00467-017-3798-x

P31

scholarly article

P356

10.1007/S00467-017-3798-X

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091899975

http://www.w3.org/2001/XMLSchema#string

P698

28939921

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology